Arrhythmias refers to alterations in the rate, rhythm, sequence, or origin of the electrical activity through the heart. It is a broad term encompassing both acute and chronic conditions alike.
Before we jump into the specific arrhythmias themselves, we will discuss some classifications, background physiology and pathophysiology of arrhythmias…
The SA node is the intrinsic pacemaker of the heart, generating impulses that travel down to the AV node, depolarising the atria in the process. The AV node then passes this impulse down the bundle of His and the bundle branches before reaching the apex. It then travels up the Purkinje fibres to depolarise the rest of the ventricles.
The normal heart rate differs depending on ages:
- Newborns: 110-150bpm
- 2 years: 85-125bpm
- 4 years: 75-115bpm
- 6 years+: 60-100bpm
🔢 Classification
We can therefore broadly classify arrhythmias as either bradyarrhythmias and tachyarrhythmias:
Bradyarrhythmias
These are defined as a heart rate <60bpm.
- Atrial/SA node origin
- Sinus bradycardia
- Sick sinus syndrome (sinus pause/sinus arrest)
- AV blocks
- 1º heart block
- 2º Mobitz I
- 2º Mobitz II
- 3º heart block
- Bundle branch blocks
- Right bundle branch block
- Left bundle branch block
Tachyarrhythmias
These are of course defined as a heart rate >100bpm.
We can classify them based on their origin and rhythm:
- Supraventricular tachyarrhythmias (SVTs)
This refers to any tachycardia that is not occurring in the ventricles, however, it includes any tachyarrhythmia above the Bundle of His. These are narrow-complex tachycardias, subclassified as:
- Regular atrial SVTs
- Sinus tachycardia
- Atrial flutter (AFL)
- Focal atrial tachycardia (FAT)
- Irregular atrial SVTs
- AFL with variable block
- Atrial fibrillation (AF)
- Multifocal atrial tachycardia (MAT)
- Regular atrioventricular SVTs:
- Paroxysmal SVTs
- AV nodal re-entrant tachycardia (synonymous with the term “SVT” often)
- AV re-entrant tachycardia - most commonly associated with Wolff-Parkinson-White syndrome
- Ventricular tachycardias (VTs)
These are broad-complex tachycardias which can be subclassified by:
- Clinical presentation
- Haemodynamically stable
- Haemodynamically unstable
- Morphology
- Monomorphic VT
- Polymorphic VT with normal QT interval
- Polymorphic VT with prolonged QT interval - Torsades de Point
- Ventricular fibrillation
- Duration
- Sustained - >30 seconds or requiring intervention.
- Non-sustained - 3 or more consecutive ventricular beats faster than 100bpm that spontaneously resolve in less than 30 seconds.
Pathophysiology
Once again we can separate bradyarrhythmias and tachyarrhythmias by their pathophysiology
Bradyarrhythmias may occur due to issues relating to:
- Automaticity
- Conduction blocks
While tachyarrhythmias occur due to:
- Automaticity
- Triggered activity
- Re-entry
The term automaticity refers to the ability to spontaneously depolarise and generate an action potential. A drop in automaticity causes a decrease in the heart rate, while a rise in automaticity increases the heart rate.
So what affects automaticity?
- Sympathetic nervous system - the sympathetic chain innervating the heart originates from the T1-T5 portion of the spinal cord. Adrenaline activates the alpha and beta adrenergic receptors within the heart (the predominating adrenergic receptor in the heart is ß1 receptors).
- Parasympathetic nervous system (PSNS) - particularly the vagus nerve. It releases acetylcholine onto muscarinic receptors in the heart to slow the heart. Sleep, athleticism, ischaemia all increase vagal tone and subsequently decrease automaticity.
- Metabolic activity - for example hyperthyroidism, hyperthermia can increase the heart’s automaticity, while hypothyroidism and hypothermia can decrease the heart’s automaticity.
- Drugs - such as ß-blockers, CCBs and digoxin.
- Hyperkalaemia - an increase in potassium concentration outside of the pacemaker cell will cause slower effluent of potassium, which increases the refractory period and slows conduction to the AV
- Raised intracranial pressure - this is indicated by Cushing’s triad which is hypertension, bradycardia, and abnormal respiration.
Aterdepolarisations are sudden swings of electrical activity that cause a depolarisation when it shouldn’t occur. It interrupts phase 2, 3 or 4 of the cardiac action potential to repolarise the heart when it should not be occurring.
- Early afterdepolarisations (EADs) occur in phase 2 or 3 (the repolarisation phases of the cardiac action potential). This means the heart doesn’t repolarise, instead it depolarises before the transmembrane potential is restored to its original point. They result in polymorphic VTs (Torsades de Pointes).
- Electrolyte imbalances - hypokalaemia, hypocalcaemia, hypomagnesemia
- Drugs - antiarrhythmics, antibiotics (macrolides), antipsychotics (haloperidol), antidepressants (TCAs and SSRIs) anti-emetics (ondansetron).
Causes of EADs include:
- Delayed afterdepolarisations (DADs) these occur during phase 4, after the heart has completely repolarised, but prior to the start of another normal action potential occurring.
- Ischaemia
- Hypoxia
- Inflammation
- Dilated cardiomyopathy
- Increased sympathetic stone
- Digoxin toxicity
Causes of DADs include:
Re-entry occurs when there is a unidirectional block in a branch of the electrical circuit that can only be passed by passing on the other side of the circuit. If the previously blocked area becomes excitable (unblocked) by the time the impulse arrives again, it will pass it and circle back, creating a loop. This loop will continue until it encounters tissue that cannot be depolarised.
Re-entry can be classified as either anatomical or functional re-entry:
- Anatomical re-entry - the blocking in this instance is an anatomical structure, such as the tricuspid valve. In this instance, the impulse will circle around the myocardial cells around the tricuspid valve. These are fixed and stable re-entry circuits.
- Functional re-entry - in this case there is no anatomical defining border of the blockage. Instead the blockage is due to variations in the electrophysiology of some myocardial cells which are not excitable. This will cause the circuit to circulate around it and emit impulses into the core (inwards) of the circuit and also outwards. The core of the circuit then becomes overwhelmed and refractory to depolarisation, thus becoming the barrier around which the circuit continues to propagate itself. These re-entry circuits are more unstable and may give rise to further re-entry circuits.
Re-entry is responsible for:
- Paroxysmal SVTs
- AV re-entrant (AVRT) - in AVRT there is an anatomical accessory pathway known as the bundle of Kent which creates a pathway between the atria and ventricles. This is what is seen in Wolff-Parkinson-White syndrome. The bundle of Kent can create 1 of 2 pathways:
- Orthodromic AVRT - orthodromic means that the impulse is travelling in the normal direction of the nerve fibre, i.e. from the AV node → ventricles. As the ventricles contract at the same time, it presents as a narrow complex tachycardia.
- Antidromic AVRT - antidromic means that the impulse is travelling in the opposite direction of the nerve fibre, i.e. from ventricles → AV node. As the ventricles depolarise at different times, it presents as a widened QRS complex tachycardia.
- AV nodal re-entry (AVNRT) - in AVNRT, it is usually scarring or fibrosis of myocardial tissue that leads to a disturbance in the regular conduction of the myocardium. This creates 2 pathways, a slow pathway and a fast pathway. The difference in the pathway speeds means that the fast pathway becomes refractory while the slow pathway depolarises. The impulse from the slow pathway will then travel back up the fast pathway when it becomes excitable, thus establishing a re-entry circuit.
- Atrial flutter
- Atrial fibrillation
Atrial flutter is most often caused by an anatomical re-entrant circuit that is facilitated by the cavotricuspid isthmus which enables the action potential to return to the atria.
The entirety of the pathophysiology of AF can be found in the page on atrial fibrillation. In short, it is due to multiple foci that spontaneously fire action potentials, creating re-entry circuits that enter the AV node and travel to the ventricles.
- Ventricular tachycardia
- Ventricular fibrillation
This is from a single focus found in the ventricles that fires an action potential which creates a re-entry circuit. Ventricular tachycardias may be monomorphic (MVT) or polymorphic (PVT). A specific type of PVT is Torsades de Pointes (TdP) which has a distinct “twisting” morphology. We will discuss these in depth later on.
Similar to AF, where there are multiple foci firing action potentials, creating multiple re-entrant circuits. However, VF is much more dangerous and is fatal.
Conduction blocks, as the name implies, are blockages in the conduction pathway. They ultimately slow the rate of conduction and lead to many of the bradyarrhythmias as a result.
They may occur due to:
- Ischaemia
- Hyperkalaemia
- Fibrosis
- Drugs
- Lyme disease
- Infiltrative disorders - such as amyloidiosis or sarcoidosis.
- Sick sinus syndrome
Bradyarrhythmias are defined as arrhythmias with a heart rate of <60bpm.
Sinus bradycardia, is simply a slow heart rate that is otherwise normal.
It may be due to certain conditions, but is also an indicator of good physical fitness.
Some situations that may cause sinus bradycardia include:
- Vasovagal syncope
- Sick sinus syndrome
- Acute myocardial infarction - especially inferior infarctions.
- Drugs - such as ß-blockers, digoxin, amiodarone and verapamil.
- Hypothyroidism
- Hypothermia
- Raised ICP
- Cholestasis
AV blocks
AV blocks occur due to a disruption in the conduction through the AV node. The cause of AV blocks can vary, ranging from ischemia and infiltration disorders to drugs and sick sinus syndrome.
We can subdivide them into:
- 1º heart block
- 2º heart block - Mobitz I and Mobitz II.
- 3º heart block - a complete heart block, often due to inferior MI
⚠️ Causes
- Increased vagal tone - as seen in athletes commonly.
- Acute inferior MI - as the right coronary artery supplies the AV node. A prolonged PR interval may be observed, indicating that there has been compromised supply to the AV node (as the PR interval indicates the time taken for the conduction to pass from the atria to the ventricles).
- Electrolyte abnormalities - such as hyperkalaemia.
- Drugs - such as ß-blockers, non-dihydropyridine CCBs, digoxin, cholinesterase inhibitors (such as donepezil and galantamine used in the treatment of Alzheimer’s disease).
- Myocarditis
🧰 Management
It is often benign and requires no treatment. If there is an underlying cause that is pathological we should treat the underlying cause.
This is known as Wenckebach phenomenon. It is a gradual prolongation of the PR interval over multiple heart cycles which eventually will result in a complete blockage of the atrial impulse which is observed as an absent QRS complex). The cycle will then restart until another P-wave is blocked.
The reason for this is that there is a dysfunctional AV node that takes longer to repolarise. This slows the conduction and prolongs the PR interval as a result. As the AV node becomes more refractory it eventually reaches a state where it becomes exhausted and completely refractory and thus we have a dropped QRS complex. This drop resets the AV node and the cycle then starts over.
⚠️ Causes
- Increased vagal tone - as seen in athletes commonly.
- Myocardial infarction - mainly inferior MI.
- Drugs - such as ß-blockers, non-dihydropyridine CCBs, digoxin.
- Myocarditis
- Cardiac surgery
🧰 Management
- Asymptomatic - monitor only. No need for intervention.
- Symptomatic
- 🥇 Stop culpable drugs if the patient is taking any.
- 🥈 Cardiac pacemaker
Atropine may be given if the patient is bradycardic.
This is also known as Hay block. This occurs when atrial impulses are sporadically blocked. The PR interval remains constant (but may be prolonged). It is of more serious concern as it generally progresses to 3º AV block and may also reduce cardiac output. Most patients have a blockage in the bundle branches, but about 20% have a blockage within the bundle of His.
⚠️ Causes
- Infarction - especially anterior MI which affects the bundle branches.
- Surgery - mitral valve repair/septal ablation.
- Inflammatory - rheumatic heart disease, SLE, systemic sclerosis, myocarditis.
- Fibrosis - Lenegre’s disease which is idiopathic fibrosis of the cardiac conduction system.
- Infiltration - Lenore’s, haemochromatosis, amyloidosis.
- Drugs - such as ß-blockers, non-dihydropyridine CCBs, digoxin, amiodarone.
🧰 Management
- 🥇 Treat underlying cause
- 🥇 Stop culpable drugs
- 🥇 Temporary pacing - with transcutaneous or transvenous pacers.
- 🏆 Permanent pacemaker - this is the definitive management option as these patients are at risk of complete heart block and haemodynamic instability.
Mobitz I and Mobitz II may cause “fixed ratio blocks”. This is where we can count the number of P-waves present before each block. It is represented as a P-wave:QRS-complex ratio. For example:
- If every 3rd P-wave is blocked, it is known as a 3:2 block. This is the most common type.
- If every 4th P-wave is blocked, it is known as a 4:3 block.
- If every 5th P-wave is blocked, it is known as a 5:4 block.
2-to-1 block may be difficult to discern due to the short nature of the cycle. It may not be possible to see the PR prolongation.
It may also be referred to as AV dissociation. In this type of AV block, no impulses from the atria are conducted to the ventricles and therefore the atria and ventricles are dissociated. What enables the ventricles to continue pumping is an ectopic focus distal to the block. These escape rhythms are not reliable however as they may not occur and they may also not be able to generate sufficient contractility (and cardiac output). It may occur as a progression of 2º AV block (especially Mobitz II).
Causes
- Myocardial infarction - particularly inferior infarction.
- Drugs - such as ß-blockers, non-dihydropyridine CCBs.
- Idiopathic fibrosis (Lenegre’s disease)
😷 Presentation
- Syncope
- Heart failure
- Regular bradycardia - 30-50bpm.
- Widened pulse pressure - >40mmHg difference between systolic and diastolic pressures.
- Cannon A waves on JVP waveform - due to the right atrium contracting against a closed tricuspid valve.
🧰 Management
- 🥇Treat underlying cause
- 🥇 Stop culpable drugs
- 🥇 Temporary pacing - with transcutaneous or transvenous pacers.
- 🏆 Permanent pacemaker - this is the definitive management option as these patients are at risk of complete heart block and haemodynamic instability.
Bundle branch blocks (BBB)
Our intraventricular conduction system is made up of:
- Bundle of His
- Left bundle branch
- Right bundle branch
- Fascicles of the left bundle branch
We will be focusing on:
- Right bundle branch block (RBBB)
- Left bundle branch block (LBBB)
In RBBB, there is a disruption in the right bundle branch that leads to impaired conduction through the bundle and subsequently impaired conduction through the right ventricle. This doesn’t mean that the ventricle is totally impaired as it will receive a compensatory electrical impulse that spreads from the left ventricle. However, this of course will be slow which causes a prolonged QRS complex on the ECG.
In RBBB, the conduction pattern is as follows:
- The left ventricle becomes activated by the left bundle branch as per usual.
- The septum and left ventricle is depolarised normally, producing a QRS complex that is normal.
- The right ventricle then depolarises across the septum, which produces a delayed depolarisation of the right ventricle. This is indicated as a delayed R-wave in leads V1-V3 (which pick up the electrical activity from the right-hand side of the heart). It is also seen as a deep S-wave in V5-V6 (which picks up the activity from the left-hand side of the heart).
⚠️ Causes
- Normal variation - this is especially true when there is an RSR pattern but a QRS complex is narrow (<120ms). It is more common with increasing age.
- Right ventricular hypertrophy and increased right ventricular pressure
- Pulmonary embolism - this is theorised to be due to acute dilatation of the right ventricle that can lead to a lack of blood flow to the vessels in the right bundle.
- Myocardial infarction
- Atrial septal defect - specifically ostium secundum (which is a hole in the atrial septum).
- Cardiomyopathy
- Myocarditis
In LBBB, the blockage in the left bundle branch results in the impulse travelling via the right bundle branch first, then to the right ventricle and then to the left ventricle via the septum. It is usually the left side of the septum that depolarises towards the right side (which are seen as Q-waves in lateral leads). This reversal of septal activation then eliminates the Q-waves in the lateral leads.
⚠️ Causes
A new-onset LBBB is always considered pathological. It may occur due to CHARM:
- Cardiomyopathy
- Hypertension
- Aortic stenosis
- Rare - idiopathic fibrosis digoxin toxicity, hyperkalaemia.
- Myocardial infarction
Let’s quickly discuss diagnosing MI in patients with an already existing LBBB:
As mentioned previously, the term appropriate discordance refers to the fact that abnormal depolarisation should be followed by abnormal repolarisation.
In LBBB, this means that lateral leads with tall, broad R-waves will often be accompanied by ST-depression and T-wave inversion. The same is true for V1 which has deep S-waves, as it may have an amount of ST-elevation that does not indicate ischaemia (usually 25% of the size of the preceding S-wave).
We can use the Smith-Modified Sgarbossa Criteria to detect MI in patients with existing LBBB:
It requires 1 of the following 3 to be true for myocardial ischaemia to be diagnosed:
- Concordant ST-elevation >1mm in leads with a positive QRS complex
- Concordant ST-depression >1mm in >1 lead of V1-V3
- Proportionally excessive discordant ST-elevation in >1 lead anywhere with >1mm ST-elevation (defined by >25% of the depth of the preceding S-wave).
😷 Presentation
- Asymptomatic
If symptomatic, it can present as such:
- Fatigue
- Nausea
- Dizziness
- Syncope
- Breathlessness
- Chest pain
Syncope, breathlessness and chest pain are red-flag symptoms that may indicate sudden cardiac death.
🔍 Investigations
- 12-lead ECG
- U&Es - to assess for any electrolyte abnormalities such as hyperkalaemia.
- Digoxin levels - if the patient is taking digoxin.
🧰 Management
The Resuscitation Council UK guidelines state that the management of bradycardia is dependant on certain factors:
- Identification of haemodynamic compromise as seen by:
- Acute severe heart failure
- Myocardial ischaemia
- Shock
- Syncope
- Identification of potential risk of asystole as seen in:
- 2º Mobitz II AV block
- 3º AV block
- Recent asystole
- Ventricular pause >3 seconds
- If there are signs of haemodynamic instability or if they are haemodynamically stable and show risk of asystole, we need to manage them as follows:
- 🥇 IV atropine - 500mcg. It is repeated every 3-5 minutes if necessary with a maximum of 6 doses being given (3mg). Atropine should not be given in patients who have had a heart transplant.
- Hypotensive patients with an inferior MI who are unresponsive to atropine are likely to have had a right ventricle infarction.
If this is not satisfactory, we have certain options:
- 🥈 IV adrenaline/isoprenaline
- 🥈 Dobutamine - if there is concomitant systolic heart failure.
- 🥈 Other drugs may be considered, such as aminophylline, dopamine, glucagon (especially in patients who have had ß-blocker or CCB overdoses), glycopyrollate.
🥈Consider temporary cardiac pacing if the patient is unresponsive to medication:
- Transcutaneous (external) pacing
- Transvenous pacing
- If haemodynamically stable WITHOUT risks of asystole:
- Identify underlying cause
- If reversible and mild → fix it.
- If reversible but sever → fix it + temporary pacing.
- If irreversible but mild → monitor.
- If irreversible and severe → permanent pacemaker.
Conditions that may warrant a permanent pacemaker include:
- 3º AV block
- 2º Mobitz II AV block
- Symptomatic sick sinus syndrome
- Permanent bradyarrhythmias caused by infarction
- Severe heart failure with an ejection fraction <35%.
- Drug-resistant tachyarrhythmias
Above we had classified the arrhythmias anatomically based on their site, but now let’s talk about how we can classify them based on the width of their QRS complex as seen on an ECG:
Narrow complex tacharrhythmias
These have a rate of >100bpm with a narrow QRS complex (<120ms - which is seen as 3 small squares on ECG).
Narrow complex with regular rhythm
- Sinus tachycardia
- Atrial flutter
- Focal atrial tachycardia - this is a subset of supraventricaular tachycardia originating from a single ectopic focus that is not the SA node.
- AV nodal re-entrant tachycardia
- AV re-entrant tachycardia (Wolff-Parkinson-White syndrome)
Narrow complex with irregular rhythm
- Atrial fibrillation
- Atrial flutter with variable AV block
- Multifocal atrial tachycardia (MAT) - a rapid irregular atrial rhythm arising from multiple ectopic foci within the atria. It is associated with COPD.
Broad complex tachyarrhythmias
These have a rate of >100bpm with a broad QRS complex (>120ms).
Broad complex with regular rhythm
- Monomorphic ventricular tachycardia
- Supraventricular tachycardia with bundle branch block
Broad complex with irregular rhythm
- Torsades de Pointes (polymorphic VT)
- Atrial flutter with Wolff-Parkinson-White syndrome
- Atrial fibrillation with bundle branch block
- Ventricular fibrillation
This is a regular, narrow complex tachycardia with the focus originating in the SA node (as it normally should be). It is defined as a sinus rhythm with a resting heart rate >100bpm in adults.
It is the most common type of tachycardia as it is a normal physiological response to stimuli.
What are some causes of sinus tachycardia?
- Pain
- Exercise
- Anxiety
- Hypovolaemia
- Hypoxia
- Pulmonary embolism - remember that this is the most common ECG finding, but PE can also present with the S1Q3T3 pattern as well.
- Cardiac tamponade
- Hyperthyroidism
- Alcohol withdrawal
- Sepsis
- Drugs - sympathomimetics (such as amphetamines, cocaine), antimuscarinics (atropine, antihistamines, TCAs), ß-agonists (adrenaline, salbutamol, dobutamine, isoprenaline)
These are all “appropriate” causes of sinus tachycardia.
Inappropriate sinus tachycardia is a primary condition in which there is persistent sinus tachycardia without an underlying cause.
🧰 Management
- Appropriate sinus tachycardia → manage underlying cause.
- Inappropriate sinus tachycardia → generally we can leave it alone. However, we can also give ß-blockers or ivabradine which have a negative chronotropic effect on the heart.
Atrial flutter is a type of SVT with a highly organised electrical circuit within the right atrium. It’s pathophysiology is as described above (re-entry due to the cavotricuspid isthmus). The direction in which the circuit travels can be either clockwise or anti-clockwise (anti-clockwise is more common).
In atrial flutter the atria contract at very high rates. However, it is important to note that the heart rate we count on an ECG is reflective of the ventricular contractions (as we typically count the R-waves which depicts ventricular apex depolarisation). In atrial flutter, the atrial rate typically varies from 250-320bpm.
The ventricular rate is not the same, however. It is only a fraction of the atrial rate, and the rate that is conducted through the AV node is dependent on the degree of “AV block” associated with it. The term AV block in this context is actually wrong as the AV node functions normally. It simply refers to the physiological response that the AV node exhibit is which prevents passage of all the electrical impulses from the atria to the ventricles. This is due to the relatively long refractory period that the AV node has.
Let’s look at an example:
If the atrial rate is contracting at 300bpm:
- 2:1 block - the ventricular rate will be 300 ÷ 2 = 150bpm. 2:1 block is the most common AV block associate with atrial flutter.
- 3:1 block - the ventricular rate will be 300 ÷ 3 = 100bpm.
- 4:1 block - the ventricular rate will be 300 ÷ 4 = 75bpm.
3:1 block and 4:1 block usually occur in the setting of underlying cardiac disease or with medications that block the AV node (ABCD - adenosine, ß-blockers, CCBs, digoxin). Sometimes atrial flutter may not be as regular. This is known as atrial flutter with variable block (for example, there is 3:1 block followed by 2:1 block).
⚠️ Causes
- In most patients it will occur due to acute illness.
- Treating patients with Wolff-Parkinson-White syndrome with AV nodal blocking medication can cause 1:1 flutter.
- Atrial fibrillation - it may convert to atrial flutter due to alterations in the atrial activity. The ECG may show fluctuations between both rhythms in the same patient.
🚨 Conversely, atrial flutter may lead to atrial fibrillation due to stretching of the atria which can then precipitate atrial fibrillation.
🧰 Management
- Haemodynamically unstable
- Immediate synchronised DC cardioversion
- Parenteral anticoagulation - if new-onset and is not on anti-coagulation already.
- Haemodynamically stable
- 🥇 Rate control - with AV nodal blocking drugs such as ß-blockers, CCBs, digoxin.
- 🥇 Treat underlying cause
- 🥇 Anti-coagulation - apixaban is the first-line option. It is dependant on the CHA₂-DS₂-VASc score.
🥈 If refractory → DC cardioversion.
🔪 If it is chronic atrial flutter or refractory atrial flutter then the definitive management is ablation of the cavotricuspid isthmus which yields a 90% success rate. It is important to note that ablation does not prevent the patient from developing atrial fibrillation.
AVNRT is a paroxysmal, narrow-complex, regular tachycardia with a heart-rate of 140-280bpm. The term paroxysmal refers to spontaneous attacks that may reoccur again and again. It may be spontaneous or it may be provoked (with exertion, caffeine, alcohol, ß-agonists, sympathomimetics).
It is the most common cause of palpitations with normal heart structures and is not life-threatening.
There are 3 variants of AVNRT :
- Slow-fast AVNRT - makes up 80-90% of cases.
- Fast-slow AVNRT
- Slow-slow AVNRT
We won’t be discussing the features of fast-slow and slow-slow in the ECG findings, rather focusing on slow-fast AVNRT.
⚠️ Risk factors
- Female gender - about 75% of cases occur in women.
- Chronic heart disease - although it may occur in young and healthy patients.
😷 Presentation
- Rapid, regular palpitations
- Presyncope/syncope
- Chest pain
- Dyspnoea
- Anxiety
- Polyuria - this is rare but may be due to elevated atrial pressures which can cause atrial natriuretic peptide to be released (increasing natriuresis).
AVRT is a paroxysmal SVT that occurs in patients who have accessory pathways present. This is typically due to formation of a re-entry circuit between the AV node and the accessory pathway. They may be orthodromic and antidromic as mentioned previously.
On ECG we can differentiate orthodromic and antidromic:
- Orthodromic AVRT → narrow QRS complex. As the impulses are being transmitted in an orthodromic direction via the AV node so the ventricles contract simultaneously.
- Antidromic AVRT → wide QRS complex. As the impulses are being transmitted from the ventricles then to AV node and thus the ventricles depolarise at different times, it presents as a widened QRS complex tachycardia.
Orthodromic AVRT is more common.
🧰 Management
- If haemodynamically unstable (severe heart failure, myocardial ischaemia, shock, syncope):
- 🥇 DC cardioversion - give up to 3 synchronised shocks.
- If haemodynamically stable:
- 🥇 Mechanical techniques - these may be contraindicated in patients with a history of cerebrovascular disease and carotid bruits.
- Valsalva manoeuvre
- Carotid sinus massage
- 🏆 IV adenosine - this is the pharmacological method of choice in which mechanical management is not sufficient or contraindicated. It is given as 6mg followed by an additional 12mg if not sufficient, followed by a final 18mg if needed. It is rapidly given over 1-3 seconds followed by a 20ml 0.9% NaCl bolus.
- Irregular SVTs should be managed as atrial fibrillation. Notes on the management of AF can be found here.
Regular rhythm
We need to block the AV node to terminate the tachycardia by preventing propagation of the impulses. we can do this with mechanical techniques (first-line) followed by pharmacological methods (gold-standard).
Adenosine causes complete blockade of the AV node transiently through agonism of the A1 receptor of the AV node. This inhibits adenylyl cyclase thus reducing cAMP and causing hyperpolarization by increasing outward potassium flux. Although it is a very useful drug when looking at narrow complex tachycardias (both diagnostically and therapeutically) it can have side effects such as chest pain, bronchospasm (avoid in asthmatics), flushing.
Dipyridimole and carbamazepine are drugs that may potentiate the effects of adenosine while theophylline can inhibit its effects.
It has a half-life of only 8-10 seconds and for this reason should be given via a large-bore cannula
It also has useful effects in patients with heart transplants to rapidly revert them to sinus rhythm, however, it is important to be aware that these patients are vert sensitive to adenosine.
Irregular rhythm
- Radiofrequency catheter ablation can be considered in recurrent episodes that are refractory to medical management. These techniques are replacing the pharmacological options for Wolff-Parkinson-White syndrome.
Wolff-Parkinson-White syndrome is a congenital disorder. It is characterised by an accessory pathway known as the bundle of Kent. This accessory pathway creates an abnormal connection between the atria and ventricles which can therefore predispose one to AVRT. The bundle bypasses the AV node and stimulates the proximal ventricles (pre-excitation). The normal conduction through the AV node occurs and this will then stimulate the ventricle for a second time (double excitation). This will only occur if the pathway is capable of antegrade conduction from atria → ventricles (bypassing the AV node) which causes and antidromic AVRT. Most of the time it is an orthodromic AVRT in WPW. In 1/3rd of cases there is only the ability to conduct from ventricles → atria and so there is no potential for pre-excitation (but there is risk of antidromic AVRT still) and this is known as concealed WPW syndrome (as no delta wave is seen).
🔢 Classification
We can classify it as type A or B depending on the side in which the bundle of Kent is present.
- Type A - left-sided bundle of Kent. Shows a dominant R wave in V1.
- Type B - right-sided bundle of Kent. Shows a dominant S wave in V1.
⚠️ Risk factors
This disorder is present in approximately 0.12% of the population.
- Male gender
- Congenital heart disease - such as Ebstein’s anomaly.
- Age 30 - 40 years old - this is the age group that most commonly presents with WPW despite it being a congenital disorder.
🚨 Complications
- Episodes of SVTs
- Sudden cardiac death - due to cardiogenic shock. This is most concerning in patients who are symptomatic.
🧰 Management
Broad complex SVTs can be difficult to distinguish from ventricular tachycardias. If any doubt is present, one should presume VT and treat it accordingly (the management will be outlined later).
- If haemodynamically unstable:
- 🥇 DC cardioversion
- If haemodynamically stable:
- 🥇 Pill-in-the-pocket - this is through:
- Flecainide (class 1c antiarrhythmic) or
- Procainamide (class 1a antiarrhythmic) or
- Sotalol (ß-blocker) - this should be avoided if there is coexistent AF as prolonging the refractory period at the AV node can increase the rate of transmission through the accessory pathway and thus increasing the ventricular rate which can further deteriorate into ventricular fibrillation.
- 🥈 Ibutilide and amiodarone (class 3 antiarrhythmics)
- 🥉 Radiofrequency catheter ablation can be considered in recurrent episodes that are refractory to medical management. These techniques are replacing the pharmacological options for Wolff-Parkinson-White syndrome.
Ventricular tachycardia is a life-threatening, broad complex tachycardia that originates from the ventricles.
It is clinically relevant because:
- Impairs cardiac output which may lead to hypotension, collapse and acute cardiac failure.
- Degeneration into ventricular fibrillation is the biggest concern as it is invariably fatal if not treated urgently.
🔢 Classification
We will look at their classification based on morphology:
- Monomorphic VT - this is a VT arising from a single focus within the ventricles. It is highly associated with myocardial infarction.
- Polymorphic VT with normal QT interval - this is a VT arising from multiple foci within the ventricles. The QRS therefore varies in amplitude, axis and duration. Most commonly due to myocardial infarction and ischaemia once again.
- Bidirectional VT - a variant of PVT associated with severe digoxin toxicity.
- Polymorphic VT with prolonged QT interval - Torsades de Pointes.
- Ventricular fibrillation - this is the most notable shockable cardiac arrest rhythm. If ALS is not initiated rapidly it will lead to certain death.
⚠️ Pathophysiology and causes
- Electrolyte abnormalities - hypokalaemia and hypomagnesaemia.
- Structural heart diseases - hypertrophic obstructive cardiomyopathy (HOCM) and myocardial infarction.
- Drugs - drugs that cause QT prolongation.
- Inherited channelopathies - such as Romano-Ward syndrome or Brugada syndrome.
Let’s take a look at some of the causes of QTc prolongation:
Congenital | Drugs | Other |
Jervell-Lange-Nielsen syndrome | Amiodarone | Electrolyte abnormalities - such as hypocalcaemia, hypokalaemia, hypomagnesaemia. |
Romano-Ward syndrome | Sotalol | Acute MI |
Flecainide and procainamide | Myocarditis | |
Tricyclic antidepressants | Hypothermia | |
Fluoxetine | Subarachnoid haemorrhage | |
Chloroquine | ||
Terfenadine | ||
Erythromycin |
🔍 Investigations
- Regular broad complex tachycardia (>120ms)
- Uniform QRS complexes
🧰 Management
⚠️ Never give verapamil with a ventricular tachycardia as it may precipitate ventricular fibrillation.
- If pulseless:
- 🥇 Immediate defibrillation (unsynchronised cardioversion) + cardiac arrest protocol
- If haemodynamically unstable:
- 🥇 Synchronised DC cardioversion - maximum of 3 attempts. They are synchronised with the R-waves.
- 🥇 Lidocaine - must be given if the patient is conscious as DC cardioversion is a painful intervention.
- 🥈 IV amiodarone - 300mg given via a central line over 10-20 mins if refractory.
- If haemodynamically stable:
- 🥇Correct electrolyte abnormalities - these are corrected via a central line.
- Hypokalaemia - give potassium chloride. Up to 60mmol (30mmol/hour) can be given.
- Hypomagnesaemia - give magnesium sulfate. 4ml of 50% MgSO4 over 30 mins.
- Hyperkalaemia
- Calcium gluconate - for cardioprotection.
- Insulin (actrapid)
- Nebulised salbutamol - may be considered. It causes shift of extracellular potassium into the intracellular space.
- Sodium bicarbonate - this may be used to correct any acidosis present with the hyperkalaemia.
- 🥇 IV amiodarone
If these two methods prove to be ineffective, the next options we have are:
- 🥈 Synchronised DC cardioversion with lidocaine as an anaesthetic agent.
Torsades de Pointes (TdP) is French for “twisting of points”. It is a specific form of PVT that occurs with QT prolongation (QTc >440ms for men and >460ms for women). It is generally self-limiting, however, it has a high risk of degenerating into VF.
It occurs due to ion channel malfunction which causes prolonged myocyte repolarisation. This then leads to EADs which are seen as tall U-waves on the ECG (U-waves are a a deflection following the T-wave usually in the same direction as the T-wave). If these U-waves reach a certain threshold, they will cause premature ventricular contractions (PVCs). If the PVC occurs during the preceding T-wave it initiates TdP (R on T phenomenon).
⭐️ For TdP to be diagnosed, there needs to be evidence of PVT and QT prolongation.
🧰 Management
- If haemodynamically unstable:
- 🥇 DC cardioversion
- If haemodynamically stable:
- 🥇 Magnesium sulfate
🚨 Avoid amiodarone as it prolongs the QTc and prolongs depolarisations.
Digoxin is a cardiac glycoside that is most commonly used in rate control for AF nowadays due to its negative chronotropic effects. It has positive inotropic effects too and is sometimes used for symptomatic improvement with heart failure.
It works by decreasing conduction through the AV node, thus slowing the ventricular effect rate in AF and atrial flutter. It also has parasympathomimetic properties which decrease SA node firing.
Simultaneously, it works to increase contractility by inhibition of the Na+/K+ ATPase pump which increases intracellular sodium levels. This sodium is used exchanged for calcium at the Na+/Ca2+ anti-porter → increased intracellular Ca2+ → increased force of contractions.
We normally do not monitor digoxin levels. However, when suspecting digoxin toxicity we can monitor the digoxin concentrations within 8-12 ours of the last dose. It is important to note that the plasma concentration alone is not the determining factor of digoxin toxicity and toxicity may occur when the concentration is within the therapeutic range.
⚠️ Risk factors
- ⭐️ Hypokalaemia - this is because digoxin normally binds to the ATPase pump where potassium binds. With hypokalaemia there is less competition of the receptor and digoxin binds more readily → toxicity.
- Increasing age
- Renal failure
- Myocardial ischaemia
- Hypomagnesaemia, hypercalcaemia, hypernatraemia
- Acidosis
- Hypoalbuminaemia
- Hypothermia
- Hypothyroidism
- Drugs - such as amiodarone, quinidine, spirinolactone, ciclosporin, thiazide and loop diuretics.
😷 Presentation
- Feeling generally unwell
- Lethargy
- Nausea and vomiting
- Anorexia
- Confusion
- Xanthopsia - a rare but classic sign characterised by yellow-green vision.
- Arrhythmias - such as AV block, bradycardia, bidirectional ventricular tachycardia.
- Gynaecomastia
- Hyperkalaemia - due to less influx of potassium as the Na+/K+ ATPase is disrupted and therefore extracellular potassium increases.
🧰 Management
- Monitor digoxin levels and cardiac monitoring
- IV fluids
- Correct electrolyte abnormalities
- Digibind/digifab - this is a digoxin-specific antibody that is given if:
- Digoxin levels >10ng/ml within 6 hours of last dose.
- Digoxin levels >15ng/ml after 6 hours of last dose.
- Symptomatic